International Pricing Index Model

January 3, 2019

Through a recent Advance Notice of Proposed Rulemaking (ANPRM), CMS discussed a model concept design for an “International Pricing Index Model (IPI)” that would initially focus on Part B single source drug and biologics that comprise a high percentage of Part B drug utilization and spending. Read related AAAAI comments.
 
Close-up of pine tree branches in Winter Close-up of pine tree branches in Winter